Pre-AIDS mortality and morbidity among injection drug users in Amsterdam and Baltimore: An ecological comparison

Substance Use and Misuse

Volumn 34, Issue 6, 1999, Pages 845-865

  Van Ameijden, Erik J C ^a   Krol, Anneke ^a   Vlahov, David ^b   Flynn, Colin ^b   Van Haastrecht, Harry J A ^c   Coutinho, Roel A ^a  

^a MUNICIPAL HEALTH SERVICE   (Netherlands)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c Div of Pub Health and Environment ^*

Author keywords

Drug overdose; Human immunodeficiency virus; Intravenous; Morbidity; Mortality; Substance use

Indexed keywords

METHADONE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG DEPENDENCE; DRUG MEGADOSE; DRUG OVERDOSE; FEMALE; HEALTH CARE ACCESS; HEALTH CARE POLICY; HOSPITALIZATION; HUMAN; INTRAVENOUS DRUG ABUSE; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; MORBIDITY; MORTALITY; MULTIPLE DRUG ABUSE; NETHERLANDS; PRIORITY JOURNAL; RISK FACTOR; SUICIDE; UNITED STATES;

EID: 0032906586     PISSN: 10826084     EISSN: None     Source Type: Journal    
DOI: 10.3109/10826089909037245     Document Type: Article

References (42)

1. BALL, J. C., LANGE, W. R., MYERS, C. P., and FRIEDMAN, S. R. (1998). Reducing the risk of AIDS through methadone maintenance treatments. J. Health Soc. Behav. 29: 214-226.
2. BUNING, E. C., VAN BRUSSEL, G. H. A., and VAN SANTEN, G. (1990). The "methadone by bus" project in Amsterdam. Br. J. Addict. 85: 1247-1250.
3. CAIAFFA, W. T., VLAHOV, D., GRAHAM, N. M. H., et al. (1994). Drug smoking, Pneumocystis carinii pneumonia, and immunosuppression increase risk of bacterial pneumonia in human immunodeficiency virus-seropositive injection drug users. Am. J. Respir. Crit. Care Med. 150: 1493-1498.
4. CAPLEHORN, J. R. M., DALTON, M. S. Y. N., CLUFF, M. C., and PETRENAS, A.-M. (1994). Retention in methadone maintenance and heroin addicts' risk of death. Addiction 89: 203-207.
5. CUNNINGHAM, W. E., MOSEN, D. M., HAYS, R. D., ANDERSEN, R. M., and SHAPIRE, M. F. (1996). Access to community based medical services and number of hospitalizations among patients with HIV-disease: Are they related? J. Acquired Immune Deficiency Syndromes Hum. Retrovirol. 13: 327-335.
6. DARKE, S., ROSS, J., and HALL, W. (1996a). Overdose among heroin users in Sydney, Australia: I. Prevalence and correlates of non-fatal overdose. Addiction 91: 405-411.
7. DARKE, S., ROSS, J., and HALL, W. (1996b). Overdose among heroin users in Sydney, Australia. II. Responses to overdose. Addiction 91: 413-417.
8. DARKE, S., and ZADOR, D. (1996). Fatal heroin "overdose": A review. Addiction 91: 1765-1772.
9. DAVOLI, M., PERUCCI, C. A., FORASTIERE, F., et al. (1993). Risk factors of overdose mortality: A case-control study within a cohort of intravenous drug users. Int. J. Epidemiol. 22: 273-277.
10. DES JARLAIS, D. C., FRIEDMAN, S. R., and WARD, T. P. (1993). Harm reduction: A public health response to the AIDS epidemic among injecting drug users. Annu. Rev. Public Health 14: 143-450.
11. EDITORIAL (1996). Suicide and overdose among opiate addicts. Addiction 91: 321-323.
12. ESKILD, A., MAGNUS, P., SAMUELSEN, S. O., SOHLBERG, C., and KITTELSEN, P. (1993). Differences in mortality rates and causes of death between HIV positive and HIV negative drug users. Int. J. Epidemiol. 22: 315-320.
13. FUGELSTAD, A., RAJS, J., BOTTIGER, M., and GERHARDSSON DE VERDIER, M. (1995). Mortality among HIV-infected intravenous drug addicts in Stockholm in relation to methadone treatment. Addiction 90: 711-716.
14. GALLI, M., and MUSICCO, M. (1994). Mortality of intravenous drug users living in Milan, Italy: Role of HIV-1 infection. Acquired Immune Deficiency Syndrome 8: 1457-1463.
15. GRONBLADH, L., OHLUND, L. S., and GUNNE, L. M. (1990). Mortality in heroin addiction: Impact of methadone treatment. Acta Psychiatr. Scand. 82: 223-227.
16. LANGENDAM, M. W., VAN HAASTRECHT, H. J. A., VAN BRUSSEL, G. H. A., VAN DEN HOEK, J. A. R., COUTINHO, R. A., and VAN AMERIJDEN, E. J. C. (1998). Differentiation in the Amsterdam methadone dispensing circuit: Determinants of methadone dosage and site of methadone prescription. Addiction 93: 61-72.
17. MANOFF, S. B., VLAHOV, D., HERSKOWITCH, A., et al. (1996). HIV infection and infective endocarditis among injecting drug users. Epidemiology 7: 566-570.
18. MIENTJES, G. H. C., MIEDEMA, F., VAN AMEIJDEN, E. J. C., VAN DEN HOEK, J. A. R., SCHELLEKENS, P. T. A., ROOS, M. T., and COUTINHO, R. A. (1991). Frequent injecting impairs lymphocyte reactivity in HIV-positive and HIV-negative drug users. Acquired Immune Deficiency Syndrome 5: 35-41.
19. MIENTJES, G. H. C., SPIJKERMAN, I. J. B., VAN AMEIJDEN, E. J. C., VAN DEN HOEK, J. A. R., and COUTINHO, R. A. (1996). Incidence and risk factors for pneumonia in HIV-infected and non-infected drug users. J. Infect. 32: 181-186.
20. MIENTJES, G. H. C., VAN AMEIJDEN, E. J. C., KEET, I. P. M., VAN DEUTEKOM, H., VAN DEN HOEK, J. A. R., and COUTINHO, R. A. (1995). Disproportional impact of the revised AIDS surveillance definition on the AIDS incidence among drug users compared to homosexual men. Eur. J. Epidemiol. 5: 288-290.
21. MIENTJES, G. H. C., VAN AMEIJDEN, E. J. C., VAN DEN HOEK, J. A. R., and COUTINHO, R. A. (1992). Increasing morbidity without rise in non-AIDS mortality among HIV-infected intravenous drug users in Amsterdam. Acquired Immune Deficiency Syndrome 6: 207-212.
22. MIENTJES, G. H. C., VAN AMEIJDEN, E. J. C., WEIGEL, H. M., VAN DEN HOEK, J. A. R., and COUTINHO, R. A. (1993). Clinical symptoms associated with seroconversion for HIV-1 among misusers of intravenous drug: Comparison with homosexual seroconverters and infected and non-infected intravenous drug misusers. Br. Med. J. 306: 371-373.
23. NEWCOMBE, R. (1996, January/February). Live and let die: Is methadone more likely to kill you than heroin? Druglink.
24. PLOMP, N. P., VAN DEN HEK, H., and ADER, H. J. (1996). The Amsterdam methadone dispensing circuit: Genesis and effectiveness of a public health model for local drug policy. Addiction 91: 711-721.
25. SCHÜTZ, C. G., RAPITI, E., VLAHOV, D., and ANTHONY, J. C. (1994). Suspected determinants of enrollment into detoxification and methadone maintenance treatment among injecting drug users. Drug Alcohol Depend. 36: 129-138.
26. SELWYN, P. A., ALCABES, P., HARTEL, D., et al. (1992). Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. New Engl. J. Med. 327: 1697-1703.
27. SELWYN, P. A., FEINGOLD, A. R., HARTEL, D., et al. (1988). Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without AIDS. Acquired Immune Deficiency Syndrome 2: 267-272.
28. SOLOMON, L., FRANK, R., VLAHOV, D., et al. (1991). Utilization of health care services in a cohort of intravenous drug users with known HIV-1 status. Am. J. Public Health 81: 1285-1290.
29. SPIJKERMAN, I. J. B., MIENTJES, G. H. C., VAN AMEIJDEN, E. J. C., VAN DEN HOEK, J. A. R., and COUTINHO, R. A. (1996). Risk factors for skin abcesses and endocarditis among injection drug users. J. Clin. Epidemiol. 49: 1149-1154.
30. STONEBURNER, R. L., DES JARLAIS, D. C., BENEZRA, D., et al. (1988). A larger spectrum of severe HIV-1 related disease in intravenous drug users in New York City. Science 242: 916-919.
31. VAN AMEIJDEN, E. J. C., VAN DEN HOEK, J. A. R., and COUTINHO, R. A. (1994a). A substantial decline in injecting risk behavior among drug users in Amsterdam from 1986 to 1992, and its relationship to AIDS prevention programs. Am. J. Public Health 84: 275-281.
32. VAN AMEIJDEN, E. J. C., VAN DEN HOEK, J. A. R., and COUTINHO, R. A. (1996). Large declines in sexual risk behavior with non-commercial partners among heterosexual injection drug users in Amsterdam, 1989-1995. Am. J. Epidemiol. 144: 772-781.
33. VAN AMEIJDEN, E. J. C., VAN DEN HOEK, J. A. R., HARTGERS, C., and COUTINHO, R. A. (1994b). Risk factors for the transition from non-injection to injection drug use and accompanying AIDS risk behavior in a cohort of drug users. Am. J. Epidemiol. 139: 1153-1163.
34. VAN AMEIJDEN, E. J. C., VAN DEN HOEK, J. A. R., VAN HAASTRECHT, H. J. A., and COUTINHO, R. A. (1994c). Trends in sexual behavior and the incidence of sexually transmitted diseases and HIV among drug using prostitutes, Amsterdam 1986-1991. Acquired Immune Deficiency Syndrome 8: 213-221.
35. VAN AMEIJDEN, E. J. C., WATTERS, J. K., VAN DEN HOEK, J. A. R., and COUTINHO, A. R. (1995). Interventions among injecting drug users: Do they work? Acquired Immune Deficiency Syndrome 9(Suppl. A): s75-s84.
36. VAN BRUSSEL, G. H. A., VAN DE WOUDE, D. H., and VAN LIESHOUT, S. J. M. (1993). Werkt het Amsterdamse sociaalmedische drugshulbeleid? Jaarbericht van de drugsafdeling CG&GD waarin opgenomen de jaarcijfers '93. Amsterdam: GG&GD, Sector GGZ.
37. VAN DEN HOEK, J. A. R., COUTINHO, R. A., VAN HAASTRECHT, H. J. A., et al. (1988). Prevalence and risk factors of HIV infections among drug users and drug using prostitutes in Amsterdam. Acquired Immune Deficiency Syndrome 2: 55-60.
38. VAN HAASTRECHT, H. J. A., BINDELS, P. J. E., SLUIJS, T. A., et al. (1996a). The impact of drug users on inpatient hospital care during the human immunodeficiency virus epidemic in Amsterdam. Int. J. Epidemiol. 25: 846-853.
39. VAN HAASTRECHT, H. J. A., MIENTJES, G. H. C., VAN DEN HOEK, J. A. R., and COUTINHO, R. A. (1994). Death from suicide and overdose among drug injectors after disclosure of first HIV test result. Acquired Immune Deficiency Syndrome 8: 1721-1725.
40. VAN HAASTRECHT, H. J. A., VAN AMEIJDEN, E. J. C., VAN DEN HOEK, J. A. R., MIENTJES, G. H. C., BAX, J. S., and COUTINHO, R. A. (1996b). Predictors of mortality in the Amsterdam cohort of human immunodeficiency virus (HIV)-positive and HIV-negative drug users. Am. J. Epidemiol. 143:380-391.
41. VLAHOV, D., ANTHONY, J. C., MUNOZ, A., et al. (1991). The ALIVE study: A longitudinal study of HIV-1 infection in intravenous drug users: Description of methods. J. Drug Issues 21: 759-776.
42. ZACCARELLI, M., GATTARI, P., REZZA, G., et al. (1994). Impact of HIV infection on non-AIDS mortality among Italian injecting drug users. Acquired Immune Deficiency Syndrome 8: 345-350.